European Strategies for Blood Pressure Control Prepared for RCI by Helen Ann Halpin, PhD October 1, 2010 Professor, SPH, UC Berkeley Deputy Editor, Public.

Slides:

Advertisements

Similar presentations

ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial The telmisartan trial in cardiovascular protection Sponsored by Boehringer.

Advertisements

Preventing Strokes One at a Time Acute Interventions and Management 2009.

BACK TO BASICS: PHARMACOLOGY CHAD C. CRIPE, MD Department of Anesthesiology & Critical Care Medicine Division of Cardiothoracic Anesthesiology The Children’s.

The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.

JNC 8 Guidelines….

ASCOT ASCOT STUDY. ASCOT INTRODUCTION AND AIMS EXISTING KNOWLEDGE BACKGROUND OF ASCOT STUDY DESIGN (TWO ARMS (BPLA,LLA) METHODOLOGY TREATMENT REGIMES.

The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure

Hypertension – Summary

Stanford Prevention Research Center STANFORD SCHOOL OF MEDICINE National Trends in the Prescribing of Anti-Hypertensive Medications Jun Ma, MD, PhD Research.

Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP

Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.

Managing Diabetes Medications. Topics What medications are available to –Manage diabetes? –Lower blood pressure? –Improve cholesterol? How can you keep.

Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.

Clinical Update on the JNC 7/8 Hypertension Guidelines

Hypertension and The Older Patient

Hypertension in the Elderly

1 The JNC 7 recommendations for initial or combination drug therapy are based on sound scientific evidence.

QUALITY USE OF CARDIOVASCULAR MEDICATION Dr Mark Abelson.

Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.

ACUTE STROKE — Hypertension is a common problem in patients with both type 1 and type 2 diabetes but the time course in relation to the duration.

Hypertension Cost effectiveness Mark Caulfield For the British Hypertension Society The William Harvey Research Institute and Barts and The London NIHR.

Selection of Antihypertensive Drug. BP ClassificationSystolic BP, mm Hg Diastolic BP, mm Hg Normal

By Judith Graham heart-attacks/ The Deadly Threat of Silent Heart Attacks.

1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.

Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal

NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf

1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.

10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.

6/3/ CARDIOVASCULAR MEDICATIONS. FIRST DO NO HARM 6/3/ There are 5 rights to patient medication administration: 1. Right patient 2. Right.

Drug List Accupril Quinapril – ACE Inhibitor – HTN & CHF.

HvC Comparative Effectiveness Project Groups 5 and 6

ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:

Impact of ACE inhibitors and Angiotensin II receptor blockers on all- cause mortality in hypertension trials Congress of the European Society of Cardiology.

Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.

HYPERTENSION RECOMMENDATIONS FOR FOLLOW UP BASED ON INITIAL BP READING

Hypertension By: Kenneth Hall and Matt McCallum Matt McCallum.

Is there evidence to justify different claims for different drug classes? Presentation to: Cardiovascular & Renal Drugs Advisory Committee Food & Drug.

ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)

Pre-ALLHAT Drug Use IMS Health NDTI, Year % of Treated Patients on Medication CCBs Beta Blockers Diuretics ACE Inhibitors.

Cardiovascular Calcium Chanel Blockers Ace Inhibitors Anticoagulant/ Diuretics Lipid Lowering.

Hypertension Hypertension can be classified as follows: Mild :Diastolic pressure mmHg Moderate: Diastolic pressure mmHg Sever: Diastolic pressure.

HYPERTENSION BY CINDY MENDEZ. BASICS Blood pressure is the force of blood pushing against blood vessel walls. The heart pumps blood into the arteries.

Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 

CCB in Management of Hypertension in Older Persons Presented by Mona Ahmed sherif Marwa Shaaban Shimaa Adel Ahmed Salma Sadek Alia khalid.

1 ALLHAT Antihypertensive Trial Results by Baseline Diabetic Status January 28, 2004.

6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.

Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).

MACROVASCULAR COMPLICATIONS, DYSLIPIDEMIA and HYPERTENSION 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.

Decreasing the Load After the Fill May the Force be with you Clearing the Path Let it Flow

Janice Herbert-Carter, MD, MGA, FACP Associate Professor of Medical Education.

Prescribing in cardiovascular disease By Jole Hannan Medicines Optimisation Pharmacist.

April 22, 2016 Connie Tien Daniel Kim Jeffrey Hughes Michelle Di Fiore

MEDICINES & THE HEART. Medicines & the Heart You and your medicines You and your medicines Common heart medicines for preventing heart disease Common.

1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 42 CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.

Internal Medicine Workshop Series Laos September /October 2009.

Management of Hypertension according to JNC 7

Hypertension JNC VIII Guidelines.

Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.

ALLHAT ALLHAT Antihypertensive Trial Results by Baseline Diabetic & Fasting Glucose Status.

The Anglo Scandinavian Cardiac Outcomes Trial

Why wasn’t a beta-blocker tested as first-line therapy?

Hypertension (High Blood Pressure)

Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy: Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene? Sumeet Gupta, MPharm, PhD,

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Table of Contents Why Do We Treat Hypertension? Recommendation 5

Primary Hypertension Max C. Reif, M.D.

Managing Blood Pressure

Internal Medicine Workshop Series Laos September /October 2009

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

Presentation transcript:

European Strategies for Blood Pressure Control Prepared for RCI by Helen Ann Halpin, PhD October 1, 2010 Professor, SPH, UC Berkeley Deputy Editor, Public Health Reviews, Sorbonne, Paris

Introduction Evidence-based hypertension treatment guidelines E.U. every 2 years; 7 year gap in U.S. 1.Compare E.U. to U.S. 2.Compare A.L.L. to E.U. 3.Role of community pharmacists in E.U.

Major Hypertension Drugs Major Hypertensions Drugs Most Prescribed: generic (Brand) Thiazide-diuretics (TD)hydrochlorothiazide (Tagamet) Beta Blockers (BB)propanolol (Inderal), atenolol (Tenormin), metoprolol (Lopressor, Toprol-XL, Inderal) Ace Inhibitors (ACEI)captopril (Capoten), lisinopril (Prinivel, Zestril), enalapril (Vasotec), benzapril(Lotesnin) Calcium Channel Blockers (CCB) nifedipine (Procardia), diltiazem (Cardizem), verapamil (Calan, Isoptin) Angiotension receptor blockers (ARB) losartan (Cozaar), losartan HCTZ (Hyzaar

Hypertension Guidelines: U.S. vs E.U. RecommendationsUS DHHSEU Last Update (2007) Next Update2011 (Fall )2011 Treatment by StageYesNo Initial TreatmentThiazide-diuretic (T-D)Two-combination drugs Drug CombinationsSilentT-D with ACEI, ARB or CCB OR ACEI with CCB Or ARB with CCB If 3rd: add T-D, ARB or CCB

Hypertension Guidelines: U.S. vs E.U. RecommendationsUS DHHSEU Treatments to AvoidNone specifiedBeta Blockers (BB) BB/T-D combinations ACEI/ARB combinations Fix-dose/single pillRecommended Low does aspirinAs an adjunct only after BP is controlled Only for patients with a previous cardiovascular event PolypillSilentNot supported Lifestyle risksWeight, sodium, activity, alcohol, smoking, fat, blood glucose

BP RCTs Published Since 2004 (40) ACTION ALLHAT ASCOT BBLTTC EDIC FEVER IDNT LIFE MOSES PROGRESS SCOPE SHEP VALUE CAFÉ DREAM ELSA FEVER HYVET INVEST MOSES PHARAO STAR Steno 2 TROPHY UKPDS VALUE ACCORD ACTION ADVANCE CAPRAF COMET INVEST JIKEY HEART LIFE PROGRESS SENIORS ACCOMPLISH ACCORD ADVANCE DIRECT HYVET I-PRESERVE JUPITER LIFE ONTARGET PROFESS TRANSCEND ADVANCE CHHIPS ELSA FEVER GISSI-AF ONTARGET PAMELA UADT VALUE

A.L.L. Protocol* vs E.U. Guidelines** Kaiser A.L.L. Protocol E.U. Blood Pressure Guidelines aspirinRecommended only following first cardiovascular event. (Serious side effects include serious bleeding from the stomach/intestine and increased risk of hemorrhagic stroke) lisinopril (ace inhibitor) Recommended in combination with Thiazide- Diuretic or CCB only Lovastatin (statin) Not recommended unless lipids are elevated. (Serious side effects include rhabdomylysis and kidney failure, peripheral neuopathy, memory loss, and delirium) 3 pills/day1 pill/day Fixed doses for allMedicate based on individual risk *for diabetic patients at risk of cvd mortality ** for treatment of high blood pressure

Community Pharmacists in E.U. Use of pharmacists as part of primary care team –Primary prevention –Detection –Management Advantages –Access –Evidence of increased compliance and improved BP control Challenges –Education and training (beyond Rx filling) –Legal duty to perform (Denmark, Spain, Belgium, France) –Contractual relationship with and payment by insurers (FFS; little evaluation) –Cooperation between physicians and pharmacists –Lack of time

Recent Policy Innovation France has established a national pharmaceutical electronic record –All community pharmacists must participate –Goal: to prevent adverse drug reactions and redundant treatments